Yahoo Finance Results
- Simply Wall St. via Yahoo FinanceDec 27 16:25 PM
Assessing Merck & Co Inc’s (NYSE:MRK) past track record of performance is a useful exercise for investors. It allows us to understand whether the company has met or exceed ...
- Reuters via Yahoo Finance2 hours ago
- TheStreet.com23 minutes ago
- Market Watch47 minutes ago
- InvestorPlace via Yahoo FinanceJan 09 17:18 PM
When it comes to pharmaceuticals, few names are as renowned as Merck & Co., Inc. (NYSE:MRK). After a disappointing third quarter earnings report, Merck stock plummeted ...
- Zacks via Yahoo FinanceJan 03 20:42 PM
Merck & Co., Inc. MRK announced that its anti-PD-1 therapy, Keytruda (pembrolizumab), has been approved in Japan for previously-treated patients with urothelial carcinoma ...
- Zacks via Yahoo FinanceJan 02 13:57 PM
Hampton, NJ-based Celldex Therapeutics, Inc. CLDX is a biopharmaceutical company developing immunotherapy technologies and other cancer-targeting biologics. The company is developing ...
- Zacks via Yahoo FinanceJan 05 14:48 PM
The drug is approved for several cancer indications including non-small cell lung cancer in combination with Eli Lilly's (LLY) Alimta and carboplatin. Price Merck & Company, Inc. Price | Merck & Company, Inc.
- GlobeNewswire via Yahoo FinanceDec 29 21:46 PM
SELLAS Life Sciences Group, Inc. Nasdaq:SLS) (SELLAS Inc. today announced that the proposed merger of the businesses of SELLAS Life Sciences Group Ltd. (SELLAS Ltd.) and Galena Biopharma, Inc.
- PR Newswire via Yahoo FinanceDec 29 22:30 PM
BOSTON, Dec. 29, 2017 /PRNewswire/ -- Juniper Pharmaceuticals (JNP), a diversified healthcare company focused on women's health, today announced that Juniper Pharma Services co-founder ...
- PR Newswire via Yahoo FinanceDec 28 12:00 PM
Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.
- Markit via Yahoo FinanceJan 16 13:01 PM
This could indicate that investors who seek to profit from falling equity prices are not currently targeting MRK. Index (PMI) data, output in the Healthcare sector is rising.
- PR Newswire via Yahoo FinanceDec 27 16:30 PM
The emergence of certain key themes in the biotechnology market is expected to drive growth in this industry to a lucrative extent. These key themes include regenerative medicine and genetics ...
- related to Merck & Co., Inc